Compare Xalatan vs. Simbrinza

Head-to-head comparisons of medication uses, side effects, ratings, and more.

Xalatan (Latanoprost)

Prescription only
Lowers eye pressure.

Xalatan (Latanoprost) lowers high pressure in the eye well and helps prevent glaucoma.

lowers eye pressure

Simbrinza ia an effective two medicine combination that is used when one medication alone is not effective, and you are looking for ease of using both medications in one drop.

Upsides
  • It's easy to use and you only need to give yourself one drop each day in the evening.
  • Can be used along with other eye drops, if needed for better results.
  • Xalatan (Latanoprost) is available generically.
  • Xalatan (Latanoprost) can increase the length, thickness, and number of your eyelashes.
  • Simbrinza may be more effective because it contains two medications
  • It is easier to take two medications in one drop.
Downsides
  • Xalatan (Latanoprost) can turn the colored part of your eye and your eyelashes brown.
  • Simbrinza may cause carbonated beverages to taste metallic..
  • You must wait 5 minutes before using another eye drop
  • Remove contact lenses and leave out for 15 minutes after using the the eyedrop
  • Not used in children under 2 years of age
Used for
  • Ocular hypertension Open-angle glaucoma
Dosage forms
  • Eye drops
  • Eye drops
Price
Lowest price near you
$13.97
Find instant savings
Lowest price near you
$154.12
Find instant savings
Want to save even more money?
Sign up now for a 30-day trial and save up to 95% at Kroger, Albertsons, Safeway, and other pharmacies.
Reviews
Not enough review data.Leave a review
Not enough review data.Leave a review
Side effects
The Xalatan (Latanoprost) FDA package insert doesn’t have numbers about how common side effects are.
The Simbrinza (Brinzolamide / Brimonidine) FDA package insert doesn’t have numbers about how common side effects are.
Risks and warnings
  • Darkening of lenses

    Replacing contact lenses to soon

  • Darkening of lashes

    Long term use

See more detailed risks and warnings
No information currently available